Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Boston Announces Canadian Approval, Launch Of PROMUS Element Plus Stent System

RELATED NEWS
Trade BSX now with 

Boston Scientific Corp. (BSX: Quote) announced Health Canada approval and market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada.

According to the company, the new stent system incorporates the platinum chromium alloy and innovative stent design of the PROMUS Element Stent with an enhanced catheter delivery system engineered for improved performance in treating patients with coronary artery disease. The company noted that it plans to begin marketing the product immediately in Canada.

Click here to receive FREE breaking news email alerts for Boston Scientific Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.